Adjuvant EGFR TKI therapy for resectable non-small cell lung cancer: new era for personalized medicine

Lung cancer is now the leading cause of cancer death in both men and women in China, accounting for 21.7% of estimated cancer deaths in 2015 (1). Lung cancer is also the leading cause of cancer death in men and the second leading cause of cancer death in women worldwide (2).